Is the increase in bronchial responsiveness or FEV1 shortly after cessation of β2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting β2-agonists
- C. P. Van Schayck
- , S. G.M. Cloosterman
- , I. D. Bijl-Hofland
- , H. Van Den Hoogen
- , H. Th M. Folgering
- , C. Van Weel
Research output: Contribution to journal › Article › peer-review
16
Citations
(Scopus)